File Delivery System Technical information - Derivatives closing files for 20130517 regenerated
Dear Customer, Closing files for all the derivatives markets have been regenerated due to missing settlement prices information in the original files. The regenerated files are available in the File Delivery Service (FDS) 20130517 folder: https://fds.nasdaqomxnordic.com/basicdata/20130517/ Best regards, NASDAQ OMX Tech Support Market Operations Transaction Services Nordics INET: +46 8 405 6410 (07:00-18:30 CET) GCF/FDS: +46 8 405 6580 (07:00-18:30 CET) Finnish: +46 8 405
Vortioxetine clinical phase III data show significant improvement in symptoms of major depression
Vortioxetine clinical phase III data show significant improvement in symptoms of major depression -- Takeda and Lundbeck present results from pivotal phase III clinical trials with vortioxetine, an investigational compound for major depression -- First presentation of results from four pivotal clinical studies of doses of up to 20 mg/day -- Clinical studies demonstrate efficacy at doses of 15 mg and 20 mg per day including an improvement of overall functioning --
Central Depository of Armenia Introduces New Depository System to Align to International Standards
The Central Depository of Armenia (CDA), part of NASDAQ OMX Group, launches a new business model of depository operations in Armenia. Thereby it will align with the best international standards, ensuring higher level of safety and efficiency of operations. This reform, that was launched at a special ceremony today, is first of all aimed at improving services provided to companies and shareholders, as well as increasing efficiency of execution and protection of their rights. Within the new mo
NEW ORLEANS, May 17, 2013 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with
Tekmira Announces Election of Directors
VANCOUVER, British Columbia, May 17, 2013 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that the nominees listed in the management proxy circular for the 2013 Annual and Special Meeting of Shareholders were elected as directors of Tekmira at the annual meeting held on May 14, 2013 in Vancouver. Detailed results of the vote for the election of directors are set out below:
Trading in Columbus A/S shares by insiders
Release no. 19/2013 Statement of transactions by members of senior management and their related parties in shares issued by Columbus A/S and related securities, cf. section 28a of the Danish Securities Trading Act. The statement is based on reports received by Columbus A/S from members of its senior management today May 17th 2013: Name: Jørgen Cadovius Senio
Meade Instruments Corp. Announces Merger Agreement; to be Acquired by Jinghua Optics & Electronics
IRVINE, Calif., May 17, 2013 (GLOBE NEWSWIRE) --
Pomerantz Grossman Hufford Dahlstrom & Gross LLP
NEW YORK, May 17, 2013 (GLOBE NEWSWIRE) -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Nam Tai Electronics, Inc. ("Nam Tai" or the "Company") (NYSE:NTE) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 13 CV 3371, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired securities of Nam Tai between August 6, 2012 and April 26, 2013, both dates inclusive (the "Class Period"). This class action seeks to recover damages against the Company and certain of its officers and directors as a result of alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.
Port Commission, Board of Pilot Commissioners Regular Meetings Set for Tuesday, May 21
HOUSTON, May 17, 2013 (GLOBE NEWSWIRE) -- The Port Commission of the Port of Houston Authority will meet in regular session on
Progenics Pharmaceuticals Inc.
Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index
TARRYTOWN, N.Y., May 17, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that it has been selected for addition to the NASDAQ Biotechnology Index
